Skip to main content

3 Result(s)

within Article Remove this filter C Munzer Remove this filter Cancer Research Remove this filter

and

  1. Article

    Open Access

    Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)

    In neuroblastoma (NB), the presence of segmental chromosome alterations (SCAs) is associated with a higher risk of relapse.

    G Schleiermacher, J Michon, A Ribeiro, G Pierron, V Mosseri… in British Journal of Cancer (2011)

    Download PDF (576 KB) View Article

  2. Article

    Open Access

    Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification

    Whereas neuroblastoma (NB) with MYCN amplification presents a poor prognosis, no single marker allows to reliably predict outcome in tumours without MYCN amplification. We report here an extensive analysis of 147...

    G Schleiermacher, J Michon, I Huon, C Dubois d'Enghien… in British Journal of Cancer (2007)

    Download PDF (561 KB) View Article

  3. Article

    Open Access

    Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy

    The purpose of this study was to evaluate the efficacy of low-dose chemotherapy in infants with localised and unresectable neuroblastoma (NB). All consecutive infants with localised NB and no N-myc amplification ...

    H Rubie, C Coze, D Plantaz, C Munzer, A S Defachelles… in British Journal of Cancer (2003)

    Download PDF (131 KB) View Article